| Title : The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomes - Triplitt_2007_J.Manag.Care.Pharm_13_S2 |
| Author(s) : Triplitt C , McGill JB , Porte D, Jr. , Conner CS |
| Ref : J Manag Care Pharm , 13 :S2 , 2007 |
| Abstract : Triplitt_2007_J.Manag.Care.Pharm_13_S2 |
| ESTHER : Triplitt_2007_J.Manag.Care.Pharm_13_S2 |
| PubMedSearch : Triplitt_2007_J.Manag.Care.Pharm_13_S2 |
| PubMedID: 18062735 |
| Title : Incretin mimetics and dipeptidyl peptidase-IV inhibitors: potential new therapies for type 2 diabetes mellitus - Triplitt_2006_Pharmacotherapy_26_360 |
| Author(s) : Triplitt C , Wright A , Chiquette E |
| Ref : Pharmacotherapy , 26 :360 , 2006 |
| Abstract : Triplitt_2006_Pharmacotherapy_26_360 |
| ESTHER : Triplitt_2006_Pharmacotherapy_26_360 |
| PubMedSearch : Triplitt_2006_Pharmacotherapy_26_360 |
| PubMedID: 16503716 |